Covid-19: Serum gets DCGI nod to restart vaccine trials
Serum is partnering AstraZeneca to carry out trials and manufacture the Oxford University’s Covid-19 vaccine doses in India. The Drugs Controller General of India (DCGI) has granted permission to the Serum Institute of India, a Pune-based vaccine maker, to resume the Covid-19 Phase 2 and Phase 3 clinical trials in India. Serum Institute received the … Read more